A detailed Monte Carlo evaluation of 192Ir dose enhancement for gold nanoparticles and comparison with experimentally measured dose enhancements

被引:4
作者
Gray, Tara [1 ]
Bassiri, Nema [2 ]
David, Shaquan [1 ]
Patel, Devanshi Yogeshkumar [1 ]
Stathakis, Sotirios [2 ]
Kirby, Neil [2 ]
Mayer, Kathryn M. [1 ]
机构
[1] Univ Texas San Antonio, Dept Phys & Astron, San Antonio, TX 78249 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, San Antonio, TX 78229 USA
关键词
gold nanoparticles; Monte Carlo simulations; dose enhancement factor; Burlin cavity theory; radiation therapy; TREATMENT PLANNING SYSTEMS; RADIATION-THERAPY; DOSIMETRIC EVALUATION; BRACHYTHERAPY; I-125; SIZE; RADIOTHERAPY; FEASIBILITY; SIMULATION; TUMORS;
D O I
10.1088/1361-6560/ab9502
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Gold nanoparticles (GNPs) have been studied extensively as promising radiation dose enhancing agents. In the current study, the dose enhancement effect of GNPs for Ir-192 HDR brachytherapy is studied using Monte Carlo N-Particle code, version 6.2 (MCNP6.2) and compared with experimental results obtained using Burlin cavity theory formalism. The Ir-192 source is verified using TG-43 parameters and dose enhancement factors (DEFs) from GNPs are simulated for three different mass percentages of gold in the GNP solution. These results are compared to DEFs previously reported experimentally by our group (Bassiriet al2019Med. Phys.) for a GNP-containing volume in an apparatus designed in-house to measure dose enhancement with GNPs for high dose rate (HDR) Ir-192 brachytherapy. An HDR Ir-192 Microselectron v2 r HDR brachytherapy source was modeled using MCNP6.2 using the TG-43 formalism in water. Anisotropy and radial dose function were verified against known values. An apparatus designed to measure dose enhancement to a 0.75 cm(3)volume of GNPs from an Ir-192 brachytherapy seed with average energy of 0.38 MeV was built in-house and modeled using MCNP6.2. Burlin cavity correction factors were applied to experimental measurements. The macroscopic DEF was calculated for GNPs of size 30 nm at mass percentages of gold of 0.28%, 0.56% and 0.77%, using the repeating structures capability of MCNP6.2. DEF was calculated by dividing dose to the GNP solution by dose to water in the same volume. The radial dose function and anisotropy factor values at varying angles and distances were accurate when compared against known values. DEFs of 1.018 +/- 0.003, 1.031 +/- 0.003, and 1.041 +/- 0.003 for GNP solutions containing mass percent of gold of 0.28%, 0.56% and 0.77%, respectively, were computed. These DEFs were within 2% of experimental values with Burlin cavity correction factors applied for all three mass percentages of gold.
引用
收藏
页数:12
相关论文
共 45 条
  • [1] Gold nanoparticles as a sensitising agent in external beam radiotherapy and brachytherapy: a feasibility study through Monte Carlo simulation
    Amato, Ernesto
    Italiano, Antonio
    Pergolizzi, Stefano
    [J]. INTERNATIONAL JOURNAL OF NANOTECHNOLOGY, 2013, 10 (12) : 1045 - 1054
  • [2] Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study
    Asadi, Somayeh
    Vaez-zadeh, Mehdi
    Vahidian, Mohammad
    Marghchouei, Mahdieh
    Masoudi, S. Farhad
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2016, 17 (03): : 90 - 99
  • [3] Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye
    Asadi, Somayeh
    Vaez-Zadeh, Mehdi
    Masoudi, S. Farhad
    Rahmani, Faezeh
    Knaup, Courtney
    Meigooni, Ali S.
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2015, 16 (05): : 344 - 357
  • [4] Technical Note: Film-based measurement of gold nanoparticle dose enhancement for 192Ir
    Bassiri, Nema
    Gray, Tara
    David, Shaquan
    Yogeshkumar Patel, Devanshi
    Locker, Andrew
    Rasmussen, Karl
    Papanikolaou, Niko
    Mayer, Kathryn M.
    Kirby, Neil
    [J]. MEDICAL PHYSICS, 2020, 47 (01) : 260 - 266
  • [5] Photoactivation of gold nanoparticles for glioma treatment
    Bobyk, Laure
    Edouard, Magali
    Deman, Pierre
    Vautrin, Mathias
    Pernet-Gallay, Karin
    Delaroche, Julie
    Adam, Jean-Francois
    Esteve, Francois
    Ravanat, Jean-Luc
    Elleaume, Helene
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 9 (07) : 1089 - 1097
  • [6] A Monte Carlo study of I-125 prostate brachytherapy with gold nanoparticles: dose enhancement with simultaneous rectal dose sparing via radiation shielding
    Brivio, D.
    Nguyen, P. L.
    Sajo, E.
    Ngwa, W.
    Zygmanski, P.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2017, 62 (05) : 1935 - 1948
  • [7] Monte Carlo and experimental dosimetric study of the mHDR-v2 brachytherapy source
    Chandola, Rakesh M.
    Tiwari, Samit
    Kowar, Manoj K.
    Choudhary, Vivek
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2010, 6 (04) : 421 - 426
  • [8] Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice
    Chang, Meng-Ya
    Shiau, Ai-Li
    Chen, Yu-Hung
    Chang, Chih-Jui
    Chen, Helen H-W
    Wu, Chao-Liang
    [J]. CANCER SCIENCE, 2008, 99 (07): : 1479 - 1484
  • [9] BSA capped Au nanoparticle as an efficient sensitizer for glioblastoma tumor radiation therapy
    Chen, Na
    Yang, Weitao
    Bao, Yun
    Xu, Hualin
    Qin, Songbing
    Tu, Yu
    [J]. RSC ADVANCES, 2015, 5 (51) : 40514 - 40520
  • [10] Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy
    Chithrani, Devika B.
    Jelveh, Salomeh
    Jalali, Farid
    van Prooijen, Monique
    Allen, Christine
    Bristow, Robert G.
    Hill, Richard P.
    Jaffray, David A.
    [J]. RADIATION RESEARCH, 2010, 173 (06) : 719 - 728